Inventor
WALTER FERLIN
Inventor
CH
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides29%
A61KPreparations for medical, dental or toiletry purposes24%
Y02ATechnologies for adaptation to climate change14%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
PatentTitleYear
12,583,922Bispecific antibodies targeting CD47 and PD-L1 and methods of use thereof202612,297,264Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications202512,275,785Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of CXCL9 and other biomarkers202512,195,530Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications202511,613,582Anti-IL-6/IL-6R antibodies and methods of use thereof202311,236,158Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to SWEDISH ORPHAN BIOVITRUM AG (4)· patent assignee history
2022–2026Based in CH· patent location history
2023–2026Patents assigned to NOVIMMUNE SA (2)· patent assignee history
2023Based in FR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AG | 4 | 2022–2025 |
| NOVIMMUNE SA | 2 | 2023–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| CH | 5 | 2022–2026 |
| FR | 1 | 2023 |